Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adverse Drug Reactions of Generic vs Brand Ceftazidime
NCT00173901Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2001
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised trial of ceftazidime in bacterial infection (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: The adverse drug reactions of ceftazidime. Status: unknown.
02
Drugs
ceftazidime
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00173901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00173901.